Robust earnings growth to continue in healthcare sector in Q3FY25: Report

New Delhi [India], January 7 (ANI): Pharma companies in India are expected to report healthy earnings growth in the just-concluded October-December quarter, averaging 19.4 per cent, as per a report by brokerage firm Motilal Oswal.

The financial services company expects aggregate sales of the domestic pharma companies to grow 10 per cent year-on-year to Rs 787 billion, aided by strong traction in domestic formulation (DF)